Optiscan Imaging Ltd - Asset Resilience Ratio
Optiscan Imaging Ltd (OIL) has an Asset Resilience Ratio of 70.98% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2007–2025)
This chart shows how Optiscan Imaging Ltd's Asset Resilience Ratio has changed over time. Check OIL strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Optiscan Imaging Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Optiscan Imaging Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$17.71 Million | 70.98% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$17.71 Million | 70.98% |
Asset Resilience Insights
- Very High Liquidity: Optiscan Imaging Ltd maintains exceptional liquid asset reserves at 70.98% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Optiscan Imaging Ltd Industry Peers by Asset Resilience Ratio
Compare Optiscan Imaging Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Henan Thinker Automation
SHG:603508 |
Scientific & Technical Instruments | 8.00% |
|
Chengdu Qinchuan IoT Technology Co Ltd
SHG:688528 |
Scientific & Technical Instruments | 2.02% |
|
Catapult Group International Ltd
AU:CAT |
Scientific & Technical Instruments | 6.17% |
|
Ikegps Group Ltd
AU:IKE |
Scientific & Technical Instruments | 22.52% |
|
Dorsavi Ltd
AU:DVL |
Scientific & Technical Instruments | 57.75% |
|
X2M Connect Ltd
AU:X2M |
Scientific & Technical Instruments | 39.95% |
|
HYDRIX Ltd
AU:HYD |
Scientific & Technical Instruments | 3.57% |
|
Wuhan Guide Infrared Co Ltd
SHE:002414 |
Scientific & Technical Instruments | 0.21% |
Annual Asset Resilience Ratio for Optiscan Imaging Ltd (2007–2025)
The table below shows the annual Asset Resilience Ratio data for Optiscan Imaging Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 43.12% | AU$4.55 Million ≈ $3.22 Million |
AU$10.56 Million ≈ $7.47 Million |
-28.74pp |
| 2024-06-30 | 71.86% | AU$11.23 Million ≈ $7.95 Million |
AU$15.63 Million ≈ $11.06 Million |
+70.71pp |
| 2023-06-30 | 1.15% | AU$53.61K ≈ $37.93K |
AU$4.67 Million ≈ $3.31 Million |
+0.48pp |
| 2022-06-30 | 0.67% | AU$53.61K ≈ $37.93K |
AU$7.98 Million ≈ $5.65 Million |
-71.51pp |
| 2021-06-30 | 72.18% | AU$8.44 Million ≈ $5.97 Million |
AU$11.70 Million ≈ $8.28 Million |
+56.90pp |
| 2020-06-30 | 15.28% | AU$526.36K ≈ $372.43K |
AU$3.44 Million ≈ $2.44 Million |
-32.81pp |
| 2019-06-30 | 48.09% | AU$1.75 Million ≈ $1.24 Million |
AU$3.64 Million ≈ $2.58 Million |
+10.25pp |
| 2018-06-30 | 37.83% | AU$1.56 Million ≈ $1.11 Million |
AU$4.13 Million ≈ $2.92 Million |
+11.56pp |
| 2017-06-30 | 26.27% | AU$700.67K ≈ $495.77K |
AU$2.67 Million ≈ $1.89 Million |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$1.82 Million ≈ $1.29 Million |
-- |
| 2012-06-30 | 5.67% | AU$67.00K ≈ $47.41K |
AU$1.18 Million ≈ $835.40K |
+5.65pp |
| 2007-06-30 | 0.02% | AU$2.87K ≈ $2.03K |
AU$11.60 Million ≈ $8.21 Million |
-- |
About Optiscan Imaging Ltd
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows;… Read more